Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide and Rituximab in Relapsed/Refractory MCL and CLL
NCT00609869Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Oct 2007
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), sponsored by Moffitt Cancer Center. Started Oct 2007; status: completed.
02
Drugs
lenalidomide
03
Conditions
mantle cell lymphoma (MCL)chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00609869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00609869.